Atypical progressive multifocal leukoencephalopathy associated with an unusual JC polyomavirus mutation

Archives of Neurology

Volumn 66, Issue 8, 2009, Pages 1021-1024

  Tallantyre, Emma C ^a   Paine, Simon M L ^a   Sharp, Colin P ^b   Lowe, James S ^a   Gran, Bruno ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA;

AGED; ARTICLE; AUTOPSY; BLOOD CELL COUNT; BRADYKINESIA; BRAIN STEM; CASE REPORT; DYSARTHRIA; GENETIC ANALYSIS; GRAY MATTER; HUMAN; HUMAN TISSUE; JC VIRUS; LEUKOPENIA; LIMB WEAKNESS; MALE; MYELOFIBROSIS; POLYOMA VIRUS; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; SPEECH DISORDER; SPLENOMEGALY; VIRUS MUTATION; WEIGHT REDUCTION; WHITE MATTER;

AGED; BRAIN; BRAIN STEM; CODON; DNA MUTATIONAL ANALYSIS; DNA, VIRAL; GENOME, VIRAL; HUMANS; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MAGNETIC RESONANCE IMAGING; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; NEUROLOGIC EXAMINATION; POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC; VIRION;

EID: 68549090986     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2009.94     Document Type: Article

References (9)

1. Yogo Y, Kitamura T, Sugimoto C, et al. Isolation of a possible archetypal JC virus DNA sequence from nonimmunocompromised individuals. J Virol. 1990;64(6): 3139-3143.
2. Berger JR, Kaszovitz B, Post MJ, Dickinson G. Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection: a review of the literature with a report of sixteen cases. Ann Intern Med. 1987;107(1):78-87.
3. van der Knapp MS, Valk J. Progressive Multifocal Leukoencephalopathy: Magnetic Resonance of Myelination and Myelin disorders. New York, NY: Springer Publishing Co, Inc; 2005:628-634.
4. García-Suárez J, de Miguel D, Krsnik I, Bañas H, Arribas I, Burgaleta C. Changes in the natural history of progressive multifocal leukoencephalopathy in HIV-negative lymphoproliferative disorders: impact of novel therapies. Am J Hematol. 2005;80(4):271-281.
5. Thomas DA, Giles FJ, Albitar M, et al. Thalidomide therapy for myelofibrosis with myeloid metaplasia. Cancer. 2006;106(9):1974-1984.
6. Verma S, Cikurel K, Koralnik IJ, et al. Mirtazapine in progressive multifocal leukoencephalopathy associated with polycythemia vera. J Infect Dis. 2007;196(5): 709-711.
7. Mischitelli M, Fioriti D, Videtta M, et al. Investigation on the role of cell transcriptional factor Sp1 and HIV-1 TAT protein in PML onset or development. J Cell Physiol. 2005;204(3):913-918.
8. Fedele CG, Polo C, Tenorio A, Niubò J, Ciardi MR, Pérez JL. Analysis of the transcriptional control region of JC polyomavirus in cerebrospinal fluid from HIV-negative patients with progressive multifocal leukoencephalopathy. J Med Virol. 2006;78(10):1271-1275.
9. Koralnik IJ. Progressive multifocal leukoencephalopathy revisited: has the disease outgrown its name? Ann Neurol. 2006;60(2):162-173.